DY vs ACA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 20, 2026

DY

44.8
AI Score
VS
ACA Wins

ACA

57.5
AI Score

Investment Advisor Scores

DY

45score
Recommendation
HOLD

ACA

58score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric DY ACA Winner
Forward P/E 25.1256 29.8507 DY
PEG Ratio 3.5018 1.8642 ACA
Revenue Growth 45.6% 1.7% DY
Earnings Growth 14.4% 448.6% ACA
Tradestie Score 44.8/100 57.5/100 ACA
Profit Margin 4.8% 16.8% ACA
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

DY 1M: -19.3% · 3M: -47.2% ACA 1M: +1.7% · 3M: +2.8%

Current Technical Phase

DY

Markdown
Sell / avoid

Price below a falling SMA50 (slope -16.4%), weak momentum, RSI 22

RSI (14): 21.9 · Price: $226.78

ACA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.5% over 20 days), RSI 82

RSI (14): 81.7 · Price: $149.05

Fundamentals Snapshot

Metric DY ACA
Market Cap — —
Forward P/E 17.4 29.1
Trailing P/E 23.0 36.3
Revenue (TTM) — —
Revenue Growth 0.5% 0.0%
Gross Margin 0.2% 0.2%
Operating Margin 0.1% 0.1%
EPS 10.95 4.06
Dividend Yield — 0.00%

Frequently Asked Questions

Based on our detailed analysis, ACA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.